Kalliopi Foteinogiannopoulou

9PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyEpidemiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 27, 2026
Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece.

|Oct 21, 2023
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD.

Sophie Vieujean, James O Lindsay, Ferdinando D'Amico

|Apr 13, 2023
Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease.

Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Eirini Theodoraki

|Jul 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

Henit Yanai, Anna Kagramanova, Oleg Knyazev

|Mar 03, 2022
Mental Health, Work Presenteeism, and Exercise in Inflammatory Bowel Disease.

Martina Sciberras, Konstantinos Karmiris, Catarina Nascimento

|Dec 05, 2021
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.

Stefano Festa, Giulia Zerboni, Lauranne A A P Derikx

Pageof 2

Frequent Collaborators

3 joint publications

Davide Giuseppe Ribaldone

3 joint publications

Maria Chaparro

3 joint publications

Idan Goren

2 joint publications

Carl Eriksson